These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 7907571

  • 1. Effectiveness of two methods for informing schizophrenic patients about neuroleptic medication.
    Kleinman I, Schachter D, Jeffries J, Goldhamer P.
    Hosp Community Psychiatry; 1993 Dec; 44(12):1189-91. PubMed ID: 7907571
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tardive dyskinesia and informed consent: myths and realities.
    Munetz MR, Roth LH, Cornes CL.
    Bull Am Acad Psychiatry Law; 1982 Dec; 10(2):77-88. PubMed ID: 6129012
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tardive dyskinesia, impaired recall, and informed consent.
    Ganguli R, Raghu U.
    J Clin Psychiatry; 1985 Oct; 46(10):434-5. PubMed ID: 2864333
    [Abstract] [Full Text] [Related]

  • 6. The effect of psychopathology on the ability of schizophrenic patients to give informed consent.
    Schachter D, Kleinman I, Prendergast P, Remington G, Schertzer S.
    J Nerv Ment Dis; 1994 Jun; 182(6):360-2. PubMed ID: 7911156
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Consent to neuroleptic medication for schizophrenia: clinical, ethical and legal issues.
    Brabbins C, Butler J, Bentall R.
    Br J Psychiatry; 1996 May; 168(5):540-4. PubMed ID: 8733791
    [Abstract] [Full Text] [Related]

  • 9. Informing patients about tardive dyskinesia.
    Munetz MR, Roth LH.
    Arch Gen Psychiatry; 1985 Sep; 42(9):866-71. PubMed ID: 2864030
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prevention and management of tardive dyskinesia.
    Jeste DV, Wyatt RJ.
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Neuroleptic modification of basic schizophrenic disorders].
    Heim M, Morgner J.
    Psychiatr Neurol Med Psychol (Leipz); 1987 May; 39(5):274-80. PubMed ID: 2888144
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of schizophrenia from the viewpoint of the patient. Studies on the course of treatment and neuroleptic treatment from a personal perspective].
    Windgassen K.
    Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1989 May; 58():1-169. PubMed ID: 2576099
    [No Abstract] [Full Text] [Related]

  • 19. Neuroleptic withdrawal in schizophrenic patients.
    Baldessarini RJ, Viguera AC.
    Arch Gen Psychiatry; 1995 Mar; 52(3):189-92. PubMed ID: 7872842
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.